We are live on ! Find out more
EIKN

Eikon Therapeutics
EIKN

52 hedge funds and large institutions have $251M invested in Eikon Therapeutics in 2026 Q1 according to their latest regulatory filings, with 52 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

47.06% more ownership

Funds ownership: 0% → 47.06% (+47%)

Holders
52
Holders Change
+52
Holders Change %
–
% of All Funds
0.64%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.06%
New
52
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$51.3M
2
BlackRock
BlackRock
New York
+$44.4M
3
FCMI
Foresite Capital Management IV
California
+$26M
4
MC
Merck & Co
New Jersey
+$22.3M
5
FCMV
Foresite Capital Management V
California
+$17.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$40.6M +$51.3M +3,836,830 New
BlackRock
2
BlackRock
New York
$35.1M +$44.4M +3,319,379 New
FCMI
3
Foresite Capital Management IV
California
$20.6M +$26M +1,943,682 New
MC
4
Merck & Co
New Jersey
$17.6M +$22.3M +1,666,666 New
FCMV
5
Foresite Capital Management V
California
$14M +$17.6M +1,318,983 New
T. Rowe Price Investment Management
6
T. Rowe Price Investment Management
Maryland
$12.9M +$16.3M +1,222,487 New
Capital World Investors
7
Capital World Investors
California
$12.1M +$15.3M +1,143,637 New
AllianceBernstein
8
AllianceBernstein
Tennessee
$10.8M +$13.7M +1,022,188 New
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$10.3M +$13M +975,834 New
VCM
10
Vanguard Capital Management
Pennsylvania
$10.3M +$13M +969,431 New
EC
11
EcoR1 Capital
California
$7.75M +$9.79M +732,606 New
BBA
12
Baker Bros. Advisors
New York
$5.88M +$7.43M +555,555 New
SCM
13
Soros Capital Management
New York
$5.13M +$6.48M +484,672 New
SG
14
StepStone Group
California
$4.18M +$5.28M +395,340 New
Canada Pension Plan Investment Board
15
Canada Pension Plan Investment Board
Ontario, Canada
$4.01M +$5.07M +379,024 New
Franklin Resources
16
Franklin Resources
California
$3.7M +$4.68M +350,000 New
Citadel Advisors
17
Citadel Advisors
Florida
$3.28M +$4.14M +310,000 New
GCGM
18
General Catalyst Group Management
Massachusetts
$3.23M +$4.08M +305,233 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$2.9M +$3.66M +273,931 New
Jane Street
20
Jane Street
New York
$2.8M +$3.54M +265,000 New
Ensign Peak Advisors
21
Ensign Peak Advisors
Utah
$2.12M +$2.67M +200,000 New
Wellington Management Group
22
Wellington Management Group
Massachusetts
$1.96M +$2.47M +185,000 New
Millennium Management
23
Millennium Management
New York
$1.86M +$2.35M +175,627 New
Blackstone Inc
24
Blackstone Inc
New York
$1.78M +$2.25M +168,338 New
BNP Paribas Asset Management
25
BNP Paribas Asset Management
France
$1.48M +$1.88M +140,344 New
1
2 3

EIKN Hedge Fund Activity: Q1 2026 in Review

52 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Eikon Therapeutics (EIKN) for Q1 2026, worth a combined $251M.

Buyers outnumbered sellers: 52 funds opened new EIKN positions and 0 closed out — a net gain of 52 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $51.3M.

  • 52 institutional investors held Eikon Therapeutics (EIKN) as of Q1 2026, up from 0 in Q4 2025.
  • Funds reported $251M of Eikon Therapeutics stock for Q1 2026.
  • 52 funds opened new Eikon Therapeutics positions in Q1 2026 and 0 closed out, a net change of +52 holders.
  • The largest Eikon Therapeutics buyer in Q1 2026 was Fidelity Investments, an estimated $51.3M added.

Based on aggregated 13F filings for Q1 2026.